Flibanserin Panel Review Will Pivot On Measurement Of Sexual Desire
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Reproductive Health Drugs Advisory Committee will weigh the best method for assessing the efficacy of Boehringer Ingelheim's Girosa for hypoactive sexual desire disorder in premenopausal women.